A considerably higher dose of the anti-tuberculosis drug rifampicin is safe and can also lead to a shorter treatment for tuberculosis and less resistance. This is what researchers from Radboud university medical center in Nijmegen, the Netherlands, write in a recent publication. With this they complete a year-long search for…
Genetic mechanism enables TB-causing bacterium to remember and rapidly respond to stress
Tuberculosis bacteria have evolved to remember stressful encounters and react quickly to future stress, according to a study by computational bioengineers at Rice University and infectious disease experts at Rutgers New Jersey Medical School (NJMS). Published online in the open-access journal mSystems, the research identifies a genetic mechanism that allows…
Recent advances in addressing tuberculosis give hope for future
In September 2018, the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, issued its Strategic Plan for Tuberculosis Research, which outlined research priorities to reduce and ultimately end the burden of tuberculosis (TB). TB is a bacterial disease that has claimed the lives of more than…
Tuberculosis breakthrough as experts find experimental vaccine
New tuberculosis vaccine moves one step closer as a trial of ‘game-changer’ jab proves it can stop the killer disease flaring up in infected patients Latent TB is when someone is infected with TB bacteria without symptoms The vaccine can protect from development of an active form of the disease…
Scientists developing new vaccine strategy for tuberculosis
For years, scientists have been trying to come up with a better way to protect people against tuberculosis, the disease caused by infection with the Mycobacterium tuberculosis (Mtb) bacteria. Texas Biomedical Research Institute Professor Jordi Torrelles, Ph.D., says new hope is on the horizon after a recent experiment performed in…